SEC Filing Summary for Bicara Therapeutics Inc.

This filing details a Form 4 filed by Robertson Scott M. on June 10, 2026, regarding transactions with Bicara Therapeutics Inc. (BCAX). The filing indicates the acquisition of 19,475 stock options with a right to buy, granted on June 9, 2026, and expiring on June 9, 2036. The exercise price is $20.56 per share. These options vest on the earlier of June 9, 2027, or the next annual stockholder meeting, contingent upon continued service. The shares underlying the options are 19,475 shares of Common Stock. The reporting owner, Robertson Scott M., is a director at Bicara Therapeutics Inc. and holds these options directly.